Press Releases

Date	Title
9/2/21	Pulse Biosciences to Participate in the H.C. Wainwright Global Investment Conference
8/19/21	Pulse Biosciences Announces Appointment of Mitchell E. Levinson as Chief Strategy Officer
8/9/21	Pulse Biosciences Reports Second Quarter 2021 Financial Results
7/26/21	Pulse Biosciences Schedules Second Quarter 2021 Financial Results Conference Call for August 9, 2021
7/1/21	Pulse Biosciences Announces $50 Million Private Placement
6/30/21	Pulse Biosciences Announces First CellFX® Procedure Performed in Canada
6/9/21	Pulse Biosciences Announces Health Canada Approval for CellFX® System
5/24/21	Pulse Biosciences to Participate in the Jefferies Healthcare Conference
5/13/21	Pulse Biosciences® Presents Clinical Study Results of Nano-Pulse Stimulation™ Technology to Clear Benign Lesions at the American Society for Laser Medicine and Surgery (ASLMS) 2021 Virtual Annual Conference
5/10/21	Pulse Biosciences Reports First Quarter 2021 Financial Results

Keyword Search